Atlas Trials

Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Clinical trial NCT04006041 · UNKNOWN

Trial details

NCT number
NCT04006041
Sponsor
Jianhua Fu
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal Squamous Cell Carcinoma by AJCC V8 StageResectable Esophageal Cancer
Start date
2019-06-25
Primary completion
2020-06-30
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.